Anbio Biotechnology (NASDAQ:NNNN) Stock Price Down 3.3% – What’s Next?

Shares of Anbio Biotechnology (NASDAQ:NNNN) fell 3.3% during mid-day trading on Thursday . The stock traded as low as $5.32 and last traded at $5.3940. 47,724 shares were traded during trading, a decline of 35% from the average session volume of 72,946 shares. The stock had previously closed at $5.58.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Anbio Biotechnology currently has a consensus rating of “Sell”.

Anbio Biotechnology Price Performance

The company has a 50 day simple moving average of $8.63 and a 200 day simple moving average of $18.30.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.